{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T22:05:20Z","timestamp":1794780320097,"version":"4.9.1"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1111\/j.1744-1609.2009.00133.x","type":"journal-article","created":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T20:02:08Z","timestamp":1242676928000},"page":"112-123","source":"Crossref","is-referenced-by-count":35,"title":["Evidence-based review of therapies at the menopause"],"prefix":"10.1097","volume":"7","author":[{"given":"Alastair H","family":"MacLennan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5694\/j.1326-5377.2006.tb00092.x","article-title":"The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004.","volume":"184","author":"MacLennan","year":"2006","journal-title":"Med J Aust"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/13697130802666251","article-title":"Continuing decline in hormone therapy use: population trends over 17 years.","volume":"12","author":"Maclennan","year":"2009","journal-title":"Climacteric"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.maturitas.2008.09.021","article-title":"The relationship between smoking and age at the menopause: a systematic review.","volume":"61","author":"Parente","year":"2008","journal-title":"Maturitas"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/gme.0b013e3181605494","article-title":"A randomized, placebo-controlled trial of the effects of physical exercises and estrogen therapy on health-related quality of life in menopausal women.","volume":"15","author":"Moriyama","year":"2008","journal-title":"Menopause"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1210\/jc.2006-1393","article-title":"Changes in body composition in women over six years at midlife: ovarian and chronological aging.","volume":"92","author":"Sowers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/bmj.315.7101.188","article-title":"Alcohol consumption may influence onset of the menopause.","volume":"315","author":"Torgerson","year":"1997","journal-title":"BMJ"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.SLA.0000059969.64262.87","article-title":"Rating the risk factors for breast cancer.","volume":"237","author":"Singletary","year":"2003","journal-title":"Ann Surg"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/01.gme.0000243566.25205.0b","article-title":"The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society.","volume":"13","year":"2006","journal-title":"Menopause"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.1097\/01.MLR.0000093479.39115.AF","article-title":"Health-related quality of life in a multiethnic sample of middle-aged women.","volume":"41","author":"Avis","year":"2003","journal-title":"Med Care"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.maturitas.2004.07.014","article-title":"Physical activity, symptoms, esteem, and life satisfaction during menopause.","volume":"52","author":"Elavsky","year":"2005","journal-title":"Maturitas"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/gme.0b013e31818c0284","article-title":"Physical activity, menopause, and quality of life: the role of affect and self-worth across time.","volume":"16","author":"Elavsky","year":"2009","journal-title":"Menopause"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archinte.166.14.1453","article-title":"Complementary and alternative therapies for the management of menopause-related symptoms.","volume":"166","author":"Nedrow","year":"2006","journal-title":"Arch Intern Med"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-145-12-200612190-00003","article-title":"Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy hormone therapy, or placebo:a randonized trial.","volume":"145","author":"Newton","year":"2006","journal-title":"Ann Intern Med"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/gme.0b013e31816054bf","article-title":"United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity.","volume":"15","author":"Mahady","year":"2008","journal-title":"Menopause"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.GME.0000058147.24036.B0","article-title":"A systematic review of herbal medicinal products for the treatment of menopausal symptoms.","volume":"10","author":"Huntley","year":"2003","journal-title":"Menopause"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13697130802566980","article-title":"Acupuncture for treating menopause hot flushes: a systematic review.","volume":"12","author":"Lee","year":"2009","journal-title":"Climacteric"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/gme.0b013e318167b902","article-title":"Treating the climacteric symptoms in Indian women with an integrated approach to yoga therapy: a randomized control study.","volume":"15","author":"Chattha","year":"2008","journal-title":"Menopause"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/01.GME.0000094356.92081.EF","article-title":"Bioidenticakl hormone therapy: a review.","volume":"11","author":"Boothby","year":"2004","journal-title":"Menopause"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13697130500487166","article-title":"The Bioidenticalbioequivalent hormone scam.","volume":"9","author":"MacLennan","year":"2006","journal-title":"Climacteric"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/13697139909025568","article-title":"The four harms of harmless therapies.","volume":"2","author":"Maclennan","year":"1999","journal-title":"Climacteric"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Non-hormonal therapies for menopausal hot flashes: systematic review and meta-analysis.","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00024677-200605020-00002","article-title":"Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal symptoms.","volume":"5","author":"Stearns","year":"2006","journal-title":"Treat Endocrinol"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1185\/03007990802161923","article-title":"Efficacy, safety, and tolerability of desvenlaflaxine 50 mgday and 100 mgday in outpatients with major depressive disorder.","volume":"24","author":"Liebowitz","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/YIC.0b013e32830cebed","article-title":"Efficacy, safety and tolerability of fixed-dose desvenlaflaxine 50 and 100 mgday for major depressive disorder in a placebo-controlled trial.","volume":"23","author":"Boyer","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"R31-5-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.AOG.0000222383.43913.ed","article-title":"Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial.","volume":"108","author":"Reddy","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R32-5-20210129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/gme.0b013e3180dca175","article-title":"Gabapentin for the treatment of menopausal hot flushes: a randomised controlled trial.","volume":"15","author":"Butt","year":"2008","journal-title":"Menopause"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Womens Health Initiative randomized controlled trial.","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Womens Health Initiative Randomized Controlled Trial.","volume":"291","year":"2004","journal-title":"JAMA"},{"key":"R35-5-20210129","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/bmj.39266.425069.AD","article-title":"Main morbidities recorded in the womens international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.","volume":"335","author":"Vickers","year":"2007","journal-title":"BMJ"},{"key":"R37-5-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jwh.2006.15.35","article-title":"Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.","volume":"15","author":"Grodstein","year":"2006","journal-title":"J Womens Health"},{"key":"R39-5-20210129","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2004.11.012","article-title":"Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis.","volume":"83","author":"Phillips","year":"2005","journal-title":"Fertil Steril"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"R41-5-20210129","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1525-1497.2004.30281.x","article-title":"Mortality associated with hormone therapy in younger and older women.","volume":"19","author":"Salpeter","year":"2004","journal-title":"J Gen Internal Med"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1497.2006.00389.x","article-title":"Coronary heart disease events associated with hormone therapy in younger and older women.","volume":"21","author":"Salpeter","year":"2006","journal-title":"J Gen intern Med"},{"key":"R43-5-20210129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/13697130410001713733","article-title":"Hormone therapy use after the Womens Health Initiative.","volume":"7","author":"MacLennan","year":"2004","journal-title":"Climacteric"},{"key":"R44-5-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13697130310001651409","article-title":"Should epidemiology, the media and quangos determine clinical practice?","volume":"7","author":"Sturdee","year":"2004","journal-title":"Climacteric"},{"key":"R45-5-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13697130601135847","article-title":"Long-term trials of HRT for cardioprotection - is this as good as it gets?","volume":"10","author":"MacLennan","year":"2007","journal-title":"Climacteric"},{"key":"R46-5-20210129","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","article-title":"Estrogen therapy and coronary-artery calcification.","volume":"356","author":"Manson","year":"2007","journal-title":"N Engl J Med"},{"key":"R47-5-20210129","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 with breast cancer and 108 411 women without breast cancer.","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"R48-5-20210129","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/humupd\/dmi041","article-title":"Current status of hormone therapy and breast cancer.","volume":"11","author":"Norman","year":"2005","journal-title":"Hum Reprod Update"},{"key":"R49-5-20210129","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/humupd\/dmi031","article-title":"Menopausal hormone therapy and risk of breast cancer. A meta-analysis of epidemiological studies and randomized controlled trials.","volume":"11","author":"Greiser","year":"2005","journal-title":"Hum Reprod Update"},{"key":"R50-5-20210129","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humupd\/dmi028","article-title":"Breast cancer risk with post menopausal hormonal treatment.","volume":"11","author":"Collins","year":"2005","journal-title":"Hum Reprod Update"},{"key":"R51-5-20210129","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone replacement therapy in the Million Women Study.","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"R52-5-20210129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Womens Health Initiative randomized trial plus progestin.","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"key":"R53-5-20210129","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archinte.166.9.1027","article-title":"Unopposed estrogen therapy and the risk of invasive breast cancer.","volume":"166","author":"Chen","year":"2006","journal-title":"Arch Intern Med"},{"key":"R54-5-20210129","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.cej.0000205026.14515.de","article-title":"Estrogen-progestogen replacement therapy and ovarian cancer: an update.","volume":"15","author":"La Vecchia","year":"2006","journal-title":"Eur J Cancer Prev"},{"key":"R55-5-20210129","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","article-title":"Ovarian cancer and hormone replacement therapy in the Million Women Study.","volume":"369","year":"2007","journal-title":"Lancet"},{"key":"R56-5-20210129","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Prentice R et al., for the Womens Health Investigators Investigators. Estrogen plus progestin and risk of venous thrombosis.","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"key":"R57-5-20210129","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"R58-5-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13697130500165911","article-title":"Prevention of osteoporosis is still a valid aim for hormone therapy.","volume":"8","author":"Sturdee","year":"2005","journal-title":"Climacteric"},{"key":"R59-5-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.gme.0000191204.38664.61","article-title":"Hormone therapy, timing of initiation, and cognition in women older than 60 years: the REMEMBER pilot study.","volume":"13","author":"MacLennan","year":"2006","journal-title":"Menopause"},{"key":"R60-5-20210129","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. Womens Health Initiative Memory Study.","volume":"291","author":"Schumaker","year":"2004","journal-title":"JAMA"},{"key":"R61-5-20210129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1212\/01.wnl.0000339037.76336.cf","article-title":"Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study.","volume":"72","author":"Resnick","year":"2009","journal-title":"Neurology"},{"key":"R62-5-20210129","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.288.17.2123","article-title":"Plassman BL et al., for the Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer Disease in older women.","volume":"288","author":"Zandi","year":"2002","journal-title":"J Am Med Assoc"},{"issue":"e023","key":"R63-5-20210129","first-page":"1","article-title":"A critique of Womens Health Initiative Studies. 2002-2006.","volume":"4","author":"Clark","year":"2006","journal-title":"Nucl Recept Signal"},{"key":"R64-5-20210129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5694\/j.1326-5377.2007.tb01084.x","article-title":"HRT: a reappraisal of the risks and benefits.","volume":"186","author":"MacLennan","year":"2007","journal-title":"Med J Aust"},{"key":"R65-5-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.maturitas.2005.02.011","article-title":"Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.","volume":"51","author":"Kenemans","year":"2005","journal-title":"Maturitas"},{"key":"R66-5-20210129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","article-title":"Foidart J et al., for the Liberate Study Group. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.","volume":"10","author":"Kennemans","year":"2009","journal-title":"Lancet Oncol"},{"key":"R67-5-20210129","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women.","volume":"359","author":"Cummings","year":"2008","journal-title":"N Engl J Med"},{"key":"R68-5-20210129","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/gme.0b013e31803167ab","article-title":"Estrogen and progestogen use in peri- and postmenopausal women. March 2007 position statement of The North American Menopause Society.","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"R69-5-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13697130701361657","article-title":"International Menopause Society updated recommendations on postmenopausal hormone therapy.","volume":"10","year":"2007","journal-title":"Climacteric"}],"container-title":["International Journal of Evidence-Based Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1111\/j.1744-1609.2009.00133.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:49:55Z","timestamp":1786038595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01258363-200906000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1744-1609.2009.00133.x","relation":{},"ISSN":["1744-1595"],"issn-type":[{"value":"1744-1595","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}